首页> 中文学位 >Critical appraisal of clinical practice guidelines on the management of diabetic foot ulcer:still a controversy.
【6h】

Critical appraisal of clinical practice guidelines on the management of diabetic foot ulcer:still a controversy.

代理获取

目录

声明

LIST OF ABBREVIATIONS

Introduction

Methods

1.1. Information sources and guideline selection

1.2. Data extraction from the guidelines.

1.3. Quality evaluation of the guideline

Results

2.1. Guideline search

2.2. Comparison of the characteristics of the guidelines

2.3. Comparison of the recommendations on the management of DFU.

2.4. Quality assessment

Discussion

Limitations of this study

Conclusion

Competing Interest

Funding

参考文献

致谢

展开▼

摘要

Objective: Despite the availability of clinical practice guidelines (CPGs), achieving optimal diabetic wound control is a major challenge in many parts of the world;the prime cause being their variable quality. This study aimed to systematically evaluate the quality of CPGs and compare their recommendations for managing diabetic foot ulcer (DFU) to facilitate health care provider make solid clinical decisions in time.
  Methods:Electronic databases were searched for CPGs written in English on the management of DFU, published between January 2006 and December 2016. We included six guidelines obtained from literature selection process. Two raters independently appraised each CPG us ing the Appraisal Guidelines Research and Evaluation II (AGREE-II) tool and the Institute of Medicine (IOM) criteria and using a novel method, we combined both AGREE-II and IOM criteria to evaluate the overall quality of the selected guidelines. In addition, we further evaluated the consistency or nonconformity of the recommendations on the management of DFU. Conflicts were resolved by mutual discussion or involving a third reviewer. Results: Based on the AGREE-II, none of the selected guidelines stoodsatisfactory in all domains. Nevertheless, the National Institute for Health and Clinical Excellence (NICE) guideline demonstrated higher scores compared to other guidelines in IOM criteria and hence recommended for clinical use. Regarding the content of the CPGs, considerable differences in DFU management recommendations arose. These variances resulted from evidence interpretation bias, different composition of the guidelines' development groups and omission of the guidelines for updating, and externally reviewing the recommendations.
  Conclusions: Most of the selected CPGs among different organizations were poor in quality, and remarkable differences exist while recommending the same clinical topic. Therefore, in order to establish a dependable guideline, preparation in accordance with the AGREE-II and IOM criteria is necessary.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号